US2005060769A1PendingUtilityA1
Homologous recombination-mediated transgene deletion in plant cells
Priority: Mar 9, 2000Filed: Apr 1, 2004Published: Mar 17, 2005
Est. expiryMar 9, 2020(expired)· nominal 20-yr term from priority
Inventors:Larry A. Gilbertson
C12N 15/8213
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process to prepare a recombined transgenic Zea mays plant or plant cell from a first transgenic Zea mays plant cell, wherein the transgene in the recombinant plant or plant cell has an altered genetic structure relative to the genetic structure of the transgene in the first transgenic plant cell, due to homologous recombination-mediated transgene deletion.
Claims
exact text as granted — not AI-modified1 . A method of preparing a fertile transgenic cell having an altered transgene insertion comprising:
a) obtaining a first transgenic cell, wherein the transgene insertion DNA sequence comprises an ancillary DNA sequence flanked by directly repeated DNA sequences; b) obtaining a plurality of progeny cells of any generation of the first transgenic cell; c) selecting a progeny transgenic in the presence of a negative selection agent wherein said ancillary DNA sequence flanked by directly repeated DNA sequences is deleted in the transgene insertion in the progeny transgenic cell as compared to the transgene insertion in the first transgenic cell.
2 . The method of claim 1 wherein said directly repeated DNA sequences are not recognized by a site-specific recombinase.
3 . The method of claim 1 wherein said transgenic cell is homozygous for the transgene insertion DNA sequence.
4 . The method of claim 1 wherein the ancillary DNA sequence flanked by directly repeated DNA sequence comprises a selectable marker gene or a reporter gene.
5 . The method of claim 4 wherein the ancillary DNA sequence flanked by directly repeated DNA sequence further comprises a negative selectable marker gene.
6 . The method of claim 5 wherein said negative selectable marker gene comprises a pehA gene, a cytosine deaminase gene, a T-DNA gene 2 gene or a thymidine kinase gene.
7 . The method of claim 6 wherein said negative selectable marker gene is a pehA gene.
8 . The method of claim 4 wherein the ancillary DNA sequence flanked by directly repeated DNA sequence comprises a bar, nptII, EPSPS, CP4, pat, GFP, uidA, or cryIA(b) gene.
9 . The method of claim 8 wherein said selectable marker gene is an NPTII, bar or pat gene.
10 . The method of claim 1 wherein said transgenic cell is a plant callus cell.
11 . The method of claim 10 wherein said plant callus cell is monocotyledonous.
12 . The monocotyledenous plant callus cell of claim 1 wherein said callus cell is obtained from maize.
13 . The method of claim 10 further comprising regenerating a transgenic plant from said plant callus cell wherein said ancillary DNA sequence flanked by directly repeated DNA sequence is deleted.
14 . The transgenic plant produced by the method of claim 13 wherein said regenerated transgenic plant lacks said ancillary DNA sequence.
15 . The transgenic plant of claim 14 wherein said plant lacks marker or reporter genes.
16 . A transgenic progeny plant of any generation of the transgenic plant of claim 14 .
17 . A seed of the transgenic plant of claim 14 .
18 . A transgenic progeny plant of any generation of the transgenic plant of claim 15 .
19 . A seed of the transgenic plant of claim 17 .
20 . The transgenic plant of claim 14 wherein said plant is monocotyledonous.
21 . The transgenic plant of claim 20 wherein said plant is maize.
22 . The transgenic plant of claim 21 which is inbred.
23 . The transgenic plant of claim 21 which is hybrid.Join the waitlist — get patent alerts
Track US2005060769A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.